Filing Details
- Accession Number:
- 0001181077-15-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-27 16:22:35
- Reporting Period:
- 2015-01-23
- Filing Date:
- 2015-01-27
- Accepted Time:
- 2015-01-27 16:22:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 817473 | American Capital Ltd | ACAS | () | 521451377 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181077 | R John Erickson | 2 Bethesda Metro Center 14Th Floor Bethesda MD 20814 | Cfo And Pres., Structured Fin. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-23 | 28,830 | $2.71 | 493,283 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-26 | 14,415 | $14.41 | 478,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options | Disposition | 2015-01-23 | 28,830 | $0.00 | 28,830 | $2.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-06-23 | 2019-06-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,279 | Indirect | ESOP |
| Common Stock | 242,155 | Indirect | By Family Trust |
| Common Stock | 97,700 | Indirect | By Family Trust |
Footnotes
- Sales made pursuant to a previously established Rule 10b5-1 Plan.
- Price reflects weighted average sales price; actual sales prices ranged from $14.33 to $14.48. The reporting person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
